Global Parkinson’s Disease Treatment Market, By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), Patient Care Setting (Hospitals, Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Parkinson’s disease treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.80% in the above mentioned forecast period.
Parkinson’s disease is the combination of progressive, degenerative neurological motor disorder, mainly affecting the dopaminergic cells of the brain. Tremor, rigidity, bradykinesia and postural volatility are some of the common symptoms of Parkinson’s disease.
The high growth in aging population and the coupled increase in the prevalence of Parkinson’s disease are amongst the important factors intensifying the growth and demand of Parkinson’s disease treatment market. In addition, the government funding for research is also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the growing usage of L-Dopa, a symptomatic dopamine replacement treatment as well as nigrostriatal system are also enhancing the growth of the market. Likewise, the rising number of generic drug manufacturers, increasing number of patient visits to the hospital owing to the availability of diagnostic laboratories and increased research and development expenditure from government and private enterprises are also lifting the market growth in the above mentioned forecast period. The patent expiry of branded drugs and strong drug pipeline will further accelerate the expansion of the Parkinson’s disease treatment market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the easy availability of alternative treatments will curb the growth of the Parkinson’s disease treatment market, whereas the lack of curable drugs and various side effects coupled with some of the drugs have the potential to challenge the growth of the Parkinson’s disease treatment market.
This Parkinson’s disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Parkinson’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Parkinson’s Disease Treatment Market Scope and Market Size
Parkinson’s disease treatment market is segmented on the basis of drug class, medical devices, route of administration, distribution channel and patient care setting. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the Parkinson’s disease treatment market is segmented into levodopa/carbidopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics, and other drugs.
- On the basis of medical devices, the Parkinson’s disease treatment market is segmented into deep brain stimulation (DBS) devices and carbidopa/levodopa enteral suspension (duopa) delivery devices.
- On the basis of route of administration, the Parkinson’s disease treatment market is segmented into oral, transdermal, subcutaneous, intestinal infusion and others.
- Based on distribution channel, the Parkinson’s disease treatment market is segmented into hospital pharmacies, clinics, retail pharmacies, and online pharmacies.
- The patient care setting segment of Parkinson’s disease treatment market is segmented into hospitals and clinics.
Parkinson’s Disease Treatment Market Country Level Analysis
Parkinson’s disease treatment market is analyzed and market size insights and trends are provided by country, drug class, medical devices, route of administration, distribution channel and patient care setting as referenced above.
The countries covered in the Parkinson’s disease treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the Parkinson’s disease treatment market owing to the increasing occurrence of the disorder and well-developed healthcare infrastructure within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the strong presence of untapped opportunities in this particular region.
The country section of the Parkinson’s disease treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Parkinson’s disease treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Parkinson’s disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Parkinson’s disease treatment market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Parkinson’s Disease Treatment Market Share Analysis
Parkinson’s disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Parkinson’s disease treatment market.
The major players covered in the Parkinson’s disease treatment market report are GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH., Impax Laboratories LLC, AbbVie Inc., Bausch Health., Lundbeck, Sun Pharmaceutical Industries Ltd., ACADIA Pharmaceuticals Inc., Merck & Co. Inc., Novartis AG, UCB S.A., Dr. Reddy’s Laboratories Ltd., WOCKHARDT., F. Hoffmann-La Roche Ltd, STADA Arzneimittel AG, Orion Corporation., Mylan N.V., Cipla Inc., Par Pharmaceutical., DAIICHI SANKYO COMPANY LIMITED., and Apotex Inc, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Parkinson’s Disease Treatment Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.